Your browser doesn't support javascript.
loading
Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis.
Kanwal, Fasiha; Khaderi, Saira; Singal, Amit G; Marrero, Jorge A; Asrani, Sumeet K; Amos, Christopher I; Thrift, Aaron P; Kramer, Jennifer R; Yu, Xian; Cao, Yumei; Luster, Michelle; Al-Sarraj, Abeer; Ning, Jing; El-Serag, Hashem B.
Afiliação
  • Kanwal F; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; VA HSR&D Center for Innovatio ns in Quality, Effectiveness, and Safety, Michael
  • Khaderi S; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Singal AG; Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
  • Marrero JA; Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
  • Asrani SK; Division of Gastroenterology, Department of Medicine, Baylor University Medical Center, Dallas, Texas.
  • Amos CI; Section of Epidemiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Thrift AP; Section of Epidemiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Kramer JR; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; VA HSR&D Center for Innovatio ns in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
  • Yu X; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; VA HSR&D Center for Innovatio ns in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
  • Cao Y; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; VA HSR&D Center for Innovatio ns in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
  • Luster M; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Al-Sarraj A; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; VA HSR&D Center for Innovatio ns in Quality, Effectiveness, and Safety, Michael
  • Ning J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • El-Serag HB; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas; VA HSR&D Center for Innovatio ns in Quality, Effectiveness, and Safety, Michael
Clin Gastroenterol Hepatol ; 21(13): 3296-3304.e3, 2023 12.
Article em En | MEDLINE | ID: mdl-37390101
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article